Disclosed herein is the use of 5-furan-2-yl-thiazo-2-yl derivatives of formula II, in particular the compounds as represented by the compounds of formula IIA-IID, or a pharmaceutically acceptable salt thereof for the manufacture of a therapeutic and/or preventive agent for migraine.